CLK1/4-IN-2

Overview

CLK1/4-IN-2 is a selective CLK1/4 inhibitor, with an IC 50 of 7 nM against CLK1 and an IC 50 of 2.3 nM against CLK4 . CLK1/4-IN-2 induces protein depletion in cancer cells and exhibits anticancer activity. CLK1/4-IN-2 can be used in research related to breast cancer , monocytic leukemia, bladder cancer , mammary adenocarcinoma and hepatocellular carcinoma.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > JAK/STAT Signaling | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > CDK | Products > Signaling Pathways > EGFR | Products > Signaling Pathways > HDAC

Product Information

• Catalog No.: HY-W409652
• CAS No.: 2101206-26-0
• Molecular Formula: C18H16FNO2S
• Molecular Weight: 329.39
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source